Clinical Trajectories and MRI-Based Triage of Uterine Leiomyoma Molecular Subtypes: A Large-Scale Retrospective Analysis of 720 Genotyped Tumors

This study investigates the clinical phenotypes and pharmacogenomic responses of different molecular subtypes of uterine leiomyomas, aiming to integrate their genetic characteristics into surgical practice and assess the predictive value of T2-weighted MRI for surgical outcomes. The authors found that specific mutations, such as MED12 and FH deficiency, correlate with distinct clinical behaviors and surgical re-intervention rates, while MRI signal characteristics can help predict these outcomes. Overall, the research highlights the importance of molecular subtyping in guiding treatment and prognosis for uterine leiomyomas.